Carnegie Investment Counsel Boosts Holdings in Abbott Laboratories $ABT

Carnegie Investment Counsel boosted its position in Abbott Laboratories (NYSE:ABT - Free Report) by 2.1% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 307,890 shares of the healthcare product maker